Guo Ming Chen
Président chez MICROPORT CARDIOFLOW MEDTECH CORPORATION
Fortune : 95 915 $ au 31/05/2024
Profil
Actuellement, Guo Ming Chen est président et directeur exécutif de MicroPort CardioFlow Medtech Corp. et directeur général et directeur de Shanghai MicroPort CardioFlow Medtech Co., Ltd. Dans sa carrière précédente, il a occupé le poste de directeur de la recherche et du développement chez Shanghai Microport Medical (Group) Co., Ltd. M. Chen a obtenu un diplôme de premier cycle et un diplôme d'études supérieures de l'université Jiao Tong de Shanghai.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/07/2023 | 742 954 ( 0,03% ) | 95 915 $ | 31/05/2024 |
Postes actifs de Guo Ming Chen
| Sociétés | Poste | Début |
|---|---|---|
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Président | 29/08/2023 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
 Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Président | 29/08/2023 |
Anciens postes connus de Guo Ming Chen
| Sociétés | Poste | Fin |
|---|---|---|
Shanghai Microport Medical (Group) Co., Ltd.
 Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Directeur Technique/Scientifique/R&D | 01/08/2016 |
Formation de Guo Ming Chen
| Shanghai Jiao Tong University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Electronic Technology |
